Vestan, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer (NCT02294565) | Vestan, Inc. | 2014-06-01 |
Track Vestan, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.